HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 59 filers reported holding HARROW HEALTH INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,896,145 | -11.0% | 688,667 | +17.9% | 0.00% | 0.0% |
Q2 2023 | $11,116,942 | +436.0% | 583,873 | +495.7% | 0.00% | – |
Q1 2023 | $2,073,955 | -19.1% | 98,013 | -43.5% | 0.00% | – |
Q4 2022 | $2,562,720 | +144.5% | 173,626 | +100.0% | 0.00% | – |
Q3 2022 | $1,048,000 | +65.8% | 86,813 | 0.0% | 0.00% | – |
Q2 2022 | $632,000 | +6.8% | 86,813 | 0.0% | 0.00% | – |
Q1 2022 | $592,000 | -16.7% | 86,813 | +5.5% | 0.00% | – |
Q4 2021 | $711,000 | -4.9% | 82,292 | 0.0% | 0.00% | – |
Q3 2021 | $748,000 | +15.4% | 82,292 | +17.9% | 0.00% | – |
Q2 2021 | $648,000 | -72.4% | 69,792 | -80.0% | 0.00% | – |
Q1 2021 | $2,352,000 | -1.6% | 348,423 | -0.0% | 0.00% | – |
Q4 2020 | $2,391,000 | +62.3% | 348,567 | +32.3% | 0.00% | – |
Q3 2020 | $1,473,000 | +10.8% | 263,566 | +3.3% | 0.00% | – |
Q2 2020 | $1,329,000 | +421.2% | 255,163 | +677.0% | 0.00% | – |
Q4 2019 | $255,000 | +71.1% | 32,838 | +23.9% | 0.00% | – |
Q3 2019 | $149,000 | -7.5% | 26,500 | +43.1% | 0.00% | – |
Q2 2019 | $161,000 | – | 18,513 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,343,817 | $40,360,000 | 16.67% |
Invenire Partners, LP | 453,794 | $5,477,293,000 | 8.38% |
Acuitas Investments, LLC | 337,949 | $4,079,000 | 4.23% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 188,539 | $2,276,000 | 2.47% |
Ophir Asset Management Pty Ltd | 1,714,464 | $20,694,000 | 1.88% |
Private Capital Management, LLC | 1,029,356 | $12,424,000 | 1.80% |
Birchview Capital, LP | 180,000 | $2,173,000 | 1.53% |
Diametric Capital, LP | 224,090 | $2,705,000 | 1.36% |
Uniplan Investment Counsel, Inc. | 694,257 | $8,379,000 | 0.64% |
EAM Investors, LLC | 224,046 | $2,704,000 | 0.59% |